Modular Medical’s (NASDAQ: MODD) latest FDA submission turns a quiet diabetes niche into a live‑wire medtech story, with an underappreciated, tubeless insulin “Pivot” that is starting to look less like a gadget and more like a platform.
A Small Cap With Big…
